<DOC>
	<DOCNO>NCT00191295</DOCNO>
	<brief_summary>Atomoxetine versus placebo Children Attention-Deficit/Hyperactivity Disorder ( ADHD )</brief_summary>
	<brief_title>Atomoxetine Versus Placebo Children With Attention Deficit/Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Patients diagnose ADHD Patients must able swallow capsule Patients must normal intelligence Patients weigh less 15 kg 75 kg Patients organic brain disease ( example , dementia traumatic brain injury residual )</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>